Q-linea AB (publ) announced that the company has signed a distribution partnership for ASTar® Instrument and consumables for France with Eurobio Scientific. In line with Q-linea's strategy to extend the commercial footprint across Europe for ASTar, France is the 6th European country with commercial coverage, either through a distribution partnership or direct Q-linea presence.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.27 SEK | -2.16% | -7.72% | -38.65% |
04-26 | Q-Linea AB Receives FDA 510(k) Clearance for the ASTar® System | CI |
03-13 | Q-linea AB Presents Strong ASTar Results At AMCLI | CI |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
14.78 EUR | +0.14% | +1.93% | 163M | ||
2.27 SEK | -2.16% | -7.72% | 24.47M | ||
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-38.65% | 24.47M | |
-16.33% | 18.62B | |
+22.02% | 1.94B | |
+0.39% | 1.68B | |
+27.15% | 1.26B | |
-10.70% | 1.03B | |
-18.27% | 938M | |
+0.66% | 783M | |
-25.07% | 628M | |
+14.62% | 535M |
- Stock Market
- Equities
- QLINEA Stock
- News Q-linea AB
- Q-linea AB Signs Distribution Partnership for ASTar Instrument and Consables for France with Eurobio Scientific